CORC

浏览/检索结果: 共3条,第1-3条 帮助

限定条件                    
已选(0)清除 条数/页:   排序方式:
Early BCR-ABL1 decline in imatinib-treated patients with chronic myeloid leukemia: results from a multicenter study of the Chinese CML alliance 期刊论文
2018, 卷号: 8, 期号: 7, 页码: 61
作者:  Zhang, Jingru;  Wang, Yingqiao;  Wang, Jianxiang;  Hu, Jianda;  Chen, Suning
收藏  |  浏览/下载:13/0  |  提交时间:2020/01/03
Dasatinib Versus Imatinib in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Have Not Achieved an Optimal Response to 3 Months of Imatinib Therapy: Dascern 会议论文
BLOOD, 2018-11-29
作者:  Cortes, Jorge E.;  Jiang, Qian;  Wang, Jianxiang;  Weng, Jianyu;  Zhu, Huanling
收藏  |  浏览/下载:11/0  |  提交时间:2020/01/03
Dasatinib Versus Imatinib in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Have Not Achieved an Optimal Response to 3 Months of Imatinib Therapy: Dascern 期刊论文
2018, 卷号: 132
作者:  Cortes, Jorge E.;  Jiang, Qian;  Wang, Jianxiang;  Weng, Jianyu;  Zhu, Huanling
收藏  |  浏览/下载:13/0  |  提交时间:2020/01/03


©版权所有 ©2017 CSpace - Powered by CSpace